Delivery Order SPE2DB22D1106-SPE2DB24FDWB3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,427.33 to AmerisourceBergen Drug Corp for the supply of Oxcarbazepine 300 mg/5 ml suspension in a 250 ml container. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and scheduled for completion by December 3, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of Oxcarbazepine 600 mg tablets, a neurological medication, with a ceiling value of $1,792.41 and a performance period through June 2025. The contract is not set aside and is a firm fixed-price type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,439.54 on November 13, 2025, for the supply of Oxcarbazepine ER 600 mg tablets in quantities of 100 units. The contract utilizes firm fixed pricing with an ultimate completion date of November 14, 2025, and carries no set-aside designation, indicating it was competitively awarded. Performance will take place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This...
- This federal contract award with the Defense Logistics Agency (DLA) Troop Support Medical is for the delivery of 250 ml bottles of Oxcarbazepine 300 mg/5 ml suspension. The fixed-price delivery order, valued at $1,757.83, was awarded to Amerisourcebergen Drug Corp's Corporate Office division on August 19, 2024, with a completion date of August 20, 2024. This contract is not associated with a set-aside program. Amerisourcebergen is a major supplier of pharmaceutical products and medical...
- The Defense Logistics Agency awarded a $1,725.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oxcarbazepine 300 mg/5 mL suspension (250 mL), an anticonvulsant medication used to treat neurological conditions. The delivery order, issued on December 8, 2025, with an ultimate completion date of December 9, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a $16,858.83 delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Oxcarbazepine ER 300 mg tablets in quantities of 100 units. The contract represents a firm fixed price delivery order with an ultimate completion date of October 22, 2025, and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major...
- The U.S. Defense Department's Medical Supply Chain awarded a $4,923.54 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Oxcarbazepine ER 600 mg tablets (100-count units). This firm fixed-price, non-set-aside contract is scheduled for ultimate completion by July 28, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under a larger contract vehicle,...
- The Defense Logistics Agency awarded a delivery order valued at $1,036.14 to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Oxcarbazepine 300 mg/5 ml suspension in 250 ml quantities. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of June 18, 2025, to be performed at the vendor's facility in Conshohocken, Pennsylvania. Oxcarbazepine is a neurological medication commonly used to treat seizure disorders and neuropathic pain conditions,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $2,869.87 firm fixed price Delivery Order is for the supply of 4558630619 - TRILEPTAL 300 MG/5 ML SUSP 250ML, a pharmaceutical product. The contract has a completion date of September 29, 2022 and does not have a set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $36,367.76, is for the delivery of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and antibiotics. The contract is not set-aside and represents open competition....
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FDWB3Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,966.93, is for the delivery of 4563374242 - Oxcarbazepine 300 mg/5 ml Suspension 250 ml. The contract is a Delivery Order with a Firm Fixed Price type and has an ultimate completion date of January 22, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.0k | 1/19/24 |